- China Pacific’s net income for the fiscal year was 27.26 billion yuan, surpassing estimates.
- Despite the beat, the net income represented a 27% year-on-year decrease.
- The estimated net income was 25.73 billion yuan.
- The final dividend per share remained steady at 1.02 yuan, the same as the previous year.
- The annualized investment yield was reported at 2.6%.
- Earnings Per Share (EPS) increased to 2.83 yuan from 2.56 yuan year-on-year.
- The basic EPS also stood at 2.83 yuan.
- Investor sentiment towards the company was largely positive, with 21 buys, 2 holds, and 2 sells.
- The company’s results were compared with past results based on values reported by the company’s original disclosures.
A look at China Pacific Insurance (Group) Co., Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Pacific Insurance (Group) Company, Ltd. is a leading insurance company in China, providing a wide range of insurance services. According to the Smartkarma Smart Scores, the company has an overall positive outlook with a score of 4 out of 5. This is a strong indication of the company’s potential for long-term growth and stability.
The company scores high in value and dividend, with a score of 5 for both factors. This means that China Pacific Insurance (Group) Co., Ltd. is considered to be undervalued and has a strong track record of paying dividends to its shareholders. Additionally, the company has a score of 4 for growth, indicating that it has a strong potential for future growth.
However, the company’s resilience and momentum scores are slightly lower, at 3 for both factors. This suggests that while China Pacific Insurance (Group) Co., Ltd. has a strong foundation, it may face some challenges in the short term. Overall, with its high scores in value, dividend, and growth, the company is well-positioned for long-term success and is a promising investment opportunity for those looking to enter the insurance market in China.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
